We are live on ! Find out more
AC

Apogem Capital Portfolio holdings

AUM $303K
1-Year Est. Return 46.01%
This Fund
S&P 500
This Quarter Est. Return
+11.6%
1 Year Est. Return
-46.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$156M
AUM Growth
+$8.96M
Cap. Flow
+$4.58M
Cap. Flow %
2.93%
Top 10 Hldgs %
21.1%
Holding
221
New
42
Increased
56
Reduced
67
Closed
33

Top Buys

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$9.82M
2
TTSH
Tile Shop Holdings
TTSH
+$4.75M
3
M icon
Macy's
M
+$1.6M
4
GPRE icon
Green Plains
GPRE
+$1.55M
5
BXC icon
BlueLinx
BXC
+$1.44M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Consumer Discretionary 15.71%
3 Industrials 13.91%
4 Financials 13.41%
5 Healthcare 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUS.U
176
DELISTED
Austerlitz Acquisition Corporation I Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
AUS.U
$116K 0.07%
11,199
-326
-3% -$3.34K
ASZ.U
177
DELISTED
Austerlitz Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
ASZ.U
$113K 0.07%
11,199
-326
-3% -$3.29K
IRTC icon
178
iRhythm Holdings
IRTC
$3.69B
$105K 0.07%
+1,588
New +$126K
ALBO
179
CALL
DELISTED
Albireo Pharma Inc
ALBO
$91K 0.06%
+2,600
New +$84.5K
AKU
180
DELISTED
Akumin Inc
AKU
$78K 0.05%
24,861
-8,118
-25% -$24.4K
AUPH icon
181
CALL
Aurinia Pharmaceuticals
AUPH
$1.96B
$66K 0.04%
+5,100
New +$65K
EVOP
182
CALL
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$61K 0.04%
+2,200
New +$62.8K
SIOX
183
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$53K 0.03%
19,401
+3,575
+23% +$8.89K
ASMB icon
184
Assembly Biosciences
ASMB
$513M
$44K 0.03%
+944
New +$46.8K
TRITW
185
DELISTED
Triterras, Inc. Warrant
TRITW
$41K 0.03%
25,799
-9,159
-26% -$12.2K
APTO
186
DELISTED
Aptose Biosciences, Inc.
APTO
$34K 0.02%
23
-3
-12% -$6.54K
ADMA icon
187
ADMA Biologics
ADMA
$1.97B
-38,346
Closed -$67K
ADT icon
188
ADT
ADT
$5.24B
-46,264
Closed -$390K
BCML icon
189
BayCom
BCML
$333M
-171,160
Closed -$3.08M
BLBD icon
190
Blue Bird Corp
BLBD
$2.41B
-8,000
Closed -$200K
BLKB icon
191
CALL
Blackbaud
BLKB
$1.59B
-6,800
Closed -$483K
BMY icon
192
Bristol-Myers Squibb
BMY
$128B
-7,332
Closed -$463K
CARR icon
193
Carrier Global
CARR
$57.6B
-21,000
Closed -$767K
CF icon
194
CALL
CF Industries
CF
$18.4B
-2,900
Closed -$132K
CF icon
195
CF Industries
CF
$18.4B
-1,539
Closed -$70K
CLLS
196
Cellectis
CLLS
$291M
-10,664
Closed -$216K
EB
197
DELISTED
Eventbrite
EB
-18,756
Closed -$416K
EFX icon
198
CALL
Equifax
EFX
$20.8B
-4,000
Closed -$725K
ESTC icon
199
Elastic
ESTC
$6.37B
-2,341
Closed -$260K
HSII
200
DELISTED
Heidrick & Struggles
HSII
-17,385
Closed -$621K

Similar funds

Apogem Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Apogem Capital held 221 positions worth $156M, up 6.1% from $148M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Apogem Capital's Q2 2021 filing shows 42 new, 56 increased, 67 reduced and 33 closed positions. Its largest new stake was Tile Shop Holdings: 567,614 shares worth $4.57M. The largest sale was Accolade Inc, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Apogem Capital's largest Q2 2021 buy was Tile Shop Holdings: 567,614 shares worth $4.57M.
  • Apogem Capital added most to Vodafone in Q2 2021, an estimated $9.82M increase.
  • Apogem Capital's biggest Q2 2021 reduction was At Home Group Inc., cutting an estimated $2.53M.
  • Apogem Capital fully exited Accolade Inc in Q2 2021, selling an estimated $10.3M.
  • Apogem Capital's ten largest holdings make up 21% of its $156M portfolio in Q2 2021.
  • Apogem Capital opened 42 new positions and closed 33 in Q2 2021.
  • Apogem Capital's portfolio value rose 6.1% quarter-over-quarter to $156M.

Based on Apogem Capital's 13F filing for Q2 2021, filed 16 Aug 2021.